Taylor Andrew Lawrence 4
4 · Orchestra BioMed Holdings, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Orchestra BioMed (OBIO) CFO Taylor Lawrence Withholds 36,352 Shares
What Happened
Taylor Andrew Lawrence, Chief Financial Officer of Orchestra BioMed (OBIO), had 36,352 shares withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs). The withholding was calculated at $4.02 per share for a notional value of approximately $146,135. No shares were sold on the open market as part of this transaction.
Key Details
- Transaction date: 2026-06-10; Filing date: 2026-06-12 (timely Form 4 filing).
- Withheld shares: 36,352 at $4.02 per share; total value ≈ $146,135.
- Transaction code: F — withholding to satisfy tax withholding obligations for vested RSUs.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnote: Issuer withheld shares to satisfy tax withholding; explicitly states no market sale occurred.
Context
This was a tax-withholding event tied to RSU vesting (not an open-market sale or purchase). Such withholding is a routine administrative step and does not necessarily indicate any change in insider sentiment. The filing appears timely under Section 16 reporting rules.
Insider Transaction Report
- Tax Payment
Common Stock, par value $0.0001 per share
[F1]2026-06-10$4.02/sh−36,352$146,135→ 593,065 total
Footnotes (1)
- [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.